L-Citrullinato-Bipyridine and L-Citrullinato-Phenanthroline Mixed Copper Complexes: Synthesis, Characterization and Potential Anticancer Activity
Metadatos
Mostrar el registro completo del ítemAutor
Ramírez Contreras, Diego; Vázquez Rodríguez, Sergio; García García, Amalia; Noriega, Lisset; Mendoza, Angel; Sánchez-Gaytán, Brenda L.; Meléndez, Francisco J.; Castro, María Eugenia; Cárdenas-García, Maura; González-Vergara, EnriqueEditorial
MDPI
Materia
citrulline anticancer mixed-copper complexes
Fecha
2024-05-31Referencia bibliográfica
Ramírez Contreras, D. et. al. Pharmaceutics 2024, 16, 747. [https://doi.org/10.3390/pharmaceutics16060747]
Patrocinador
Project 100108444-VIEP, 100256733-VIEP; Project 100233622- VIEP; PRODEP Academic Group BUAP-CA-263 (SEP, Mexico); Ministerio de Universidades and Funds Next-Generation for the Margarita Salas contract 401 (Spain)Resumen
Citrulline (C6H13N3O3) is an amino acid found in the body as a zwitterion. This means its carboxylic and amine groups can act as Lewis donors to chelate metal cations. In addition, citrulline possesses a terminal ureido group on its aliphatic chain, which also appears to coordinate. Here, two new mixed complexes of citrulline were made with 1,10-phenanthroline and 2,2′-bipyridine. These compounds, once dissolved in water, gave aquo-complexes that were subject to DFT studies and in vitro toxicity studies on cancer cell lines (HeLa, MDA-MB-231, HCT 15, and MCF7) showed promising results. Docking studies with DNA were also conducted, indicating potential anticancer properties.